Neurobiology of anxious depression: A review

Depression and Anxiety

Volumn 30, Issue 4, 2013, Pages 374-385

  Ionescu, Dawn F ^a   Niciu, Mark J ^a   Mathews, Daniel C ^a   Richards, Erica M ^a   Zarate Jr , Carlos A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

anxiety; anxious depression; biomarkers; depression; neurobiology

Indexed keywords

COGNITION; ELECTROENCEPHALOGRAPHY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HEREDITY; HUMAN; MIXED ANXIETY AND DEPRESSION; NEUROBIOLOGY; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; REVIEW;

ANXIETY; BRAIN; DEPRESSIVE DISORDER, MAJOR; ELECTROENCEPHALOGRAPHY; FUNCTIONAL NEUROIMAGING; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MAGNETIC RESONANCE IMAGING; PITUITARY-ADRENAL SYSTEM;

EID: 84876141542     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22095     Document Type: Review

References (64)

1. Rush AJ,. The varied clinical presentations of major depressive disorder. J Clin Psychiatry 2007; 68 (Suppl 8): 4-10.
2. Rao S, Zisook S,. Anxious depression: clinical features and treatment. Curr Psychiatry Rep 2009; 11: 429-436.
3. Middeldorp CM, Cath DC, Beem AL, et al. Life events, anxious depression and personality: a prospective and genetic study. Psychol Med 2008; 38: 1557-1565.
4. Middeldorp CM, Cath DC, Boomsma DI,. A twin-family study of the association between employment, burnout and anxious depression. J Affect Disord 2006; 90: 163-169.
5. Middeldorp CM, de Geus EJ, Willemsen G, et al. The serotonin transporter gene length polymorphism (5-HTTLPR) and life events: no evidence for an interaction effect on neuroticism and anxious depressive symptoms. Twin Res Hum Genet 2010; 13: 544-549.
6. Middeldorp CM, Slof-Op 't Landt MC, Medland SE, et al. Anxiety and depression in children and adults: influence of serotonergic and neurotrophic genes ? Genes Brain Behav 2010; 9: 808-816.
7. Sanderson WC, Beck AT, Beck J,. Syndrome comorbidity in patients with major depression or dysthymia: prevalence and temporal relationships. Am J Psychiatry 1990; 147: 1025-1028.
8. Fava M, Rankin MA, Wright EC, et al. Anxiety disorders in major depression. Compr Psychiatry 2000; 41: 97-102.
9. Fava M, Alpert JE, Carmin CN, et al. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med 2004; 34: 1299-1308.
10. Wiethoff K, Bauer M, Baghai TC, et al. Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project. J Clin Psychiatry 2010; 71: 1047-1054.
11. Fava M, Rush AJ, Alpert JE, et al. What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Can J Psychiatry 2006; 51: 823-835.
12. Seo HJ, Jung YE, Kim TS, et al. Distinctive clinical characteristics and suicidal tendencies of patients with anxious depression. J Nerv Ment Dis 2011; 199: 42-48.
13. Clayton PJ, Grove WM, Coryell W, et al. Follow-up and family study of anxious depression. Am J Psychiatry 1991; 148: 1512-1517.
14. Papakostas GI, Larsen K,. Testing anxious depression as a predictor and moderator of symptom improvement in major depressive disorder during treatment with escitalopram. Eur Arch Psychiatry Clin Neurosci 2011; 261: 147-156.
15. Fava M, Rush AJ, Alpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 2008; 165: 342-351.
16. Papakostas GI, Fan H, Tedeschini E,. Severe and anxious depression: combining definitions of clinical sub-types to identify patients differentially responsive to selective serotonin reuptake inhibitors. Eur Neuropsychopharmacol 2012; 22: 347-355.
17. Domschke K, Deckert J, Arolt V, et al. Anxious versus non-anxious depression: difference in treatment outcome. J Psychopharmacol 2010; 24: 621-622.
18. Joffe RT, Bagby RM, Levitt A,. Anxious and nonanxious depression. Am J Psychiatry 1993; 150: 1257-1258.
19. Altamura AC, Montresor C, Salvadori D, et al. Does comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic study. Int J Neuropsychopharmacol 2004; 7: 481-487.
20. Sandi C, Richter-Levin G,. From high anxiety trait to depression: a neurocognitive hypothesis. Trends Neurosci 2009; 32: 312-320.
21. Nissen C, Holz J, Blechert J, et al. Learning as a model for neural plasticity in major depression. Biol Psychiatry 2010; 68: 544-552.
22. Clark LA, Watson D,. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol 1991; 100: 316-336.
23. Davidson RJ, Anterior cerebral asymmetry and the nature of emotion. Brain Cogn 1992; 20: 125-151.
24. Heller W,. The neuropsychology of emotion: Developmental patterns and implications for psychopathology. In: Stein NL, Leventhal B, Trabasso T, editors. Psychology and Biological Approaches to Emotion. Hillsdale, NJ: Lawrence Erlbaum and Associates, Inc. Publishers; 1990.
25. Heller W, Etienne MA, Miller GA, Patterns of perceptual asymmetry in depression and anxiety: implications for neuropsychological models of emotion and psychopathology. J Abnorm Psychol 1995; 104: 327-333.
26. Etkin A, Schatzberg AF, Common abnormalities and disorder-specific compensation during implicit regulation of emotional processing in generalized anxiety and major depressive disorders. Am J Psychiatry 2011; 168: 968-978.
27. Waugh CE, Hamilton JP, Chen MC, et al. Neural temporal dynamics of stress in comorbid major depressive disorder and social anxiety disorder. Biol Mood Anxiety Disord 2012; 2: 11.
28. Andreescu C, Butters M, Lenze EJ, et al. fMRI activation in late-life anxious depression: a potential biomarker. Int J Geriatr Psychiatry 2009; 24: 820-828.
29. Andreescu C, Wu M, Butters MA, et al. The default mode network in late-life anxious depression. Am J Geriatr Psychiatry 2011; 19: 980-983.
30. Beekman AT, de Beurs E, van Balkom AJ, et al. Anxiety and depression in later life: co-occurrence and communality of risk factors. Am J Psychiatry 2000; 157: 89-95.
31. van Tol MJ, van der Wee NJ, van den Heuvel OA, et al. Regional brain volume in depression and anxiety disorders. Arch Gen Psychiatry 2010; 67: 1002-1011.
32. Inkster B, Rao AW, Ridler K, et al. Structural brain changes in patients with recurrent major depressive disorder presenting with anxiety symptoms. J Neuroimaging 2011; 21: 375-382.
33. Nelson BD, Sarapas C, Robison-Andrew EJ, et al. Frontal brain asymmetry in depression with comorbid anxiety: a neuropsychological investigation. J Abnorm Psychol 2012; 121: 579-591.
34. Bruder GE, Wexler BE, Stewart JW, et al. Perceptual asymmetry differences between major depression with or without a comorbid anxiety disorder: a dichotic listening study. J Abnorm Psychol 1999; 108: 233-239.
35. Grillon C, Ameli R, Goddard A, et al. Baseline and fear-potentiated startle in panic disorder patients. Biol Psychiatry 1994; 35: 431-439.
36. Morgan CA, 3rd, Grillon C, Southwick SM, et al. Exaggerated acoustic startle reflex in Gulf War veterans with posttraumatic stress disorder. Am J Psychiatry 1996; 153: 64-68.
37. Dichter GS, Tomarken AJ,. The chronometry of affective startle modulation in unipolar depression. J Abnorm Psychol 2008; 117: 1-15.
38. Dichter GS, Tomarken AJ, Shelton RC, et al. Early- and late-onset startle modulation in unipolar depression. Psychophysiology 2004; 41: 433-440.
39. Taylor-Clift A, Morris BH, Rottenberg J, et al. Emotion-modulated startle in anxiety disorders is blunted by co-morbid depressive episodes. Psychol Med 2011; 41: 129-139.
40. Bruder GE, Fong R, Tenke CE, et al. Regional brain asymmetries in major depression with or without an anxiety disorder: a quantitative electroencephalographic study. Biol Psychiatry 1997; 41: 939-948.
41. Manna CB, Tenke CE, Gates NA, et al. EEG hemispheric asymmetries during cognitive tasks in depressed patients with high versus low trait anxiety. Clin EEG Neurosci 2010; 41: 196-202.
42. Meller WH, Kathol RG, Samuelson SD, et al. CRH challenge test in anxious depression. Biol Psychiatry 1995; 37: 376-382.
43. Rao ML, Vartzopoulos D, Fels K,. Thyroid function in anxious and depressed patients. Pharmacopsychiatry 1989; 22: 66-70.
44. Cameron OG,. Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functions. Essent Psychopharmacol 2006; 7: 24-34.
45. Leonard BE, Myint A,. The psychoneuroimmunology of depression. Hum Psychopharmacol 2009; 24: 165-175.
46. Boomsma DI, Beem AL, van den Berg M, et al. Netherlands twin family study of anxious depression (NETSAD). Twin Res 2000; 3: 323-334.
47. Frediani F, Villani V, Migraine and depression. Neurol Sci 2007; 28 (Suppl 2): S161-S165.
48. Ligthart L, Nyholt DR, Penninx BW, et al. The shared genetics of migraine and anxious depression. Headache 2010; 50: 1549-1560.
49. Neumann ID, Wegener G, Homberg JR, et al. Animal models of depression and anxiety: what do they tell us about human condition ? Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 1357-1375.
50. Widerlov E, Lindstrom LH, Wahlestedt C, et al. Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively. J Psychiatr Res 1988; 22: 69-79.
51. Heilig M, The NPY system in stress, anxiety and depression. Neuropeptides 2004; 38: 213-224.
52. Obuchowicz E, Krysiak R, Herman ZS, Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs? Neurosci Biobehav Rev 2004; 28: 595-610.
53. Domschke K, Dannlowski U, Hohoff C, et al. Neuropeptide Y (NPY) gene: impact on emotional processing and treatment response in anxious depression. Eur Neuropsychopharmacol 2010; 20: 301-309.
54. Baffa A, Hohoff C, Baune BT, et al. Norepinephrine and serotonin transporter genes: impact on treatment response in depression. Neuropsychobiology 2010; 62: 121-131.
55. Binder EB, Owens MJ, Liu W, et al. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. Arch Gen Psychiatry 2010; 67: 369-379.
56. Domschke K, Lawford B, Laje G, et al. Brain-derived neurotrophic factor (BDNF) gene: no major impact on antidepressant treatment response. Int J Neuropsychopharmacol 2010; 13: 93-101.
57. Ising M, Lucae S, Binder EB, et al. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry 2009; 66: 966-975.
58. Newman SC, Bland RC,. Life events and the 1-year prevalence of major depressive episode, generalized anxiety disorder, and panic disorder in a community sample. Compr Psychiatry 1994; 35: 76-82.
59. Paykel ES,. Life events and affective disorders. Acta Psychiatr Scand Suppl 2003; 418: 61-66.
60. Middeldorp CM, The association of personality with anxious and depressive psychopathology. In:, Canli T, Editor. The Biological Basis of Personality and Individual Differences. New York: Guilford Press; 2006: 251-272.
61. Uher R, Dernovsek MZ, Mors O, et al. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. J Affect Disord 2011; 132: 112-120.
62. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th revision ed. Geneva: World Health Organization. 3 v; 1992.
63. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC; 2000.
64. Regier DA, Narrow WE, Clarke DE, et al. DSM-5 field trials in the United States and Canada, part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry 2013 Jan 1; 170 (1): 59-70.